Frost & Sullivan Podcasts

This episode of Frost & Sullivan’s Growth Podcast takes a focused look at How AI, Private 5G, Multi-access Edge Computing (MEC), and Embedded Security Fuel the IoT Transformation, drawn from our ongoing work across sectors, technologies, and competitive landscapes.

This will help you capitalize on the convergence of IoT, generative AI, MEC, and 5G to drive intelligent automation in your organization.

👉 Which emerging technologies and business models are reshaping the IoT and edge ecosystem?

👉 How can your team apply best practices and benchmarks to sharpen execution?

👉 Where should you focus next to outpace competitors and capture growth?

Expect practical takeaways designed to support real-world action and strategic clarity.

Explore related studies:

https://www.frost.com | https://store.frost.com/

Reach out to our team: [email protected]

Stationary batteries are no longer just for backup, they are the backbone of a $111 billion energy ecosystem. In this episode of Frost & Sullivan’s Growth Podcast, we explore how lithium-ion, sodium-ion, and hybrid battery systems are powering utilities, telecom, and commercial operations worldwide. Learn how batteries enable frequency regulation, peak shaving, and renewable integration while cutting costs and emissions. We will cover global market growth, second-life battery adoption, and the technology shifts making storage central to energy resilience and sustainability.

For more information, write to [email protected].

The U.S. energy ecosystem is in flux. Federal fossil fuel policies are returning, but solar, battery storage, and hydrogen are still powering growth. In this episode of Frost & Sullivan’s Growth Podcast, we examine how macroeconomic shifts, tariffs, and supply chain changes are shaping the renewable energy transition. Discover why offshore wind is slowing, how Energy-as-a-Service models are expanding, and where state-level policies are unlocking opportunity. This is your guide to navigating the evolving U.S. energy market and accelerating sustainable growth.

For more information, write to [email protected].

The global immunomodulator therapeutics market is set to accelerate rapidly, surpassing $60 billion by 2030. In this episode of Frost & Sullivan’s Growth Podcast, we explore how innovation in precision immunology is transforming treatment for autoimmune diseases, cancers, and inflammatory disorders. Discover the impact of biosimilar competition, breakthrough small-molecule and bispecific antibody therapies, and mechanism-based R&D targeting immune pathways like TYK2 and FcRn. Learn where growth opportunities lie—from women’s health to transplant therapies—and the challenges of regulation, side effects, and access. Tune in to understand how strategic agility will define the future of immunology and how companies can thrive by mastering immune system control.

For more information, write to [email protected].

In this episode of Frost & Sullivan's Growth Podcast, we explore the transformative impact of advanced visualization in medical imaging, focusing on how AI, 3D, and 4D technologies are reshaping diagnostics. With radiology departments facing unprecedented demands and challenges, we discuss how innovative tools are enhancing patient care. From 3D imaging that provides a more immersive view of anatomy to AI that assists in identifying anomalies and streamlining workflows, these advancements are crucial in addressing the growing need for accurate and timely diagnoses. We’ll delve into specific applications in neurology, oncology, and cardiovascular medicine, as well as the barriers to widespread adoption. Join me as we uncover how these technologies are not just improving radiology but are also setting the stage for a future where intelligent imaging becomes the norm in healthcare.

Welcome to the Frost & Sullivan Webinar Podcast! In this must-listen episode, we explore how lab automation is no longer optional—it’s essential. From intelligent liquid handling to AI-powered orchestration platforms, the modern lab is transforming faster than ever.

Whether you are in clinical diagnostics, pharmaceutical R&D, genomics, or biotech, this episode dives deep into the technologies reshaping how science is done. Discover how automation, no-code software, and AI are improving accuracy, speeding up workflows, and driving sustainability in labs around the world.

What you'll learn:

Why automation is accelerating across clinical and research labs

Key market trends—from robotics to compliant-ready software

How to make a strong business case for automation investments

The role of AI, data integration, and interoperability in creating the “Intelligent Lab”

Why sustainability is becoming a must-have in lab procurement

Packed with expert insights and real-world examples, this episode offers a strategic look at how labs can thrive in an era of rapid innovation.

Subscribe now and stay ahead of the curve—because the future of labs is automated, integrated, and intelligent.

Connect with us at [email protected] for more insights or collaboration opportunities.

In this episode of Frost & Sullivan’s Growth Podcast, we explore how behavioral biometrics, AI, and continuous authentication are redefining fraud prevention. From real-time detection to sector-specific customization, a new model of digital security is taking shape—one that’s adaptive, intelligent, and user-first.

🎯 Key takeaways include:

• Why behavioral biometrics is outperforming traditional verification methods

• Four strategic shifts driving innovation in fraud detection

• Sector-specific approaches to fraud defense in fintech, healthcare, and more

• Frost Radar™ benchmarking of leaders driving next-gen solutions

• The move toward frictionless, real-time, AI-powered fraud protection

This episode is essential listening for CISOs, product heads, and digital security teams looking to stay ahead of evolving threats.

frost.com | [email protected]

In this episode of Frost & Sullivan’s Growth Podcast, we reveal the top 15 companies transforming cybersecurity in healthcare infrastructure. From zero trust frameworks to AI-powered anomaly detection and managed services, these leaders are redefining how hospitals secure devices, data, and care delivery.

🎯 Key takeaways include:

• Why cybersecurity is now core to patient safety and operational continuity

• Strategic imperatives: Zero trust, microsegmentation, AI, MSS

• Benchmark insights from Armis, Cisco, Claroty, CrowdStrike, and IBM

• Growth potential in managed services and generative AI security models

• How to evaluate your own infrastructure resilience against the market

This episode is a must-listen for CIOs, IT heads, healthcare executives, and investors focused on clinical risk reduction and digital trust.

frost.com | [email protected]

In this episode of Frost & Sullivan’s Growth Podcast, we explore the companies and strategies powering India’s EV infrastructure transformation. As the country pushes toward a 100% EV future, charging access, smart scalability, and public-private collaboration will define who wins.

🎯 Key takeaways include:

• The three strategic imperatives shaping India’s EV infrastructure buildout

• How companies like Bolt.Earth and Tata Power are setting benchmarks

• Innovation levers like battery swapping, smart grids, and interoperability

• Why public-private partnerships and ecosystem convergence matter now

• What to prioritize over the next 7 years to capture long-term EV growth

Whether you're a tech provider, infrastructure investor, or mobility strategist, this episode gives you the clarity to act.

frost.com | [email protected]

In this episode of Frost & Sullivan’s Growth Podcast, we explore how electroceuticals are transforming chronic disease management—from pain to neurodegeneration. With wearable formats, AI-driven personalization, and hybrid therapy models, this market is scaling fast and redefining long-term care.

🎯 Key takeaways include:

• How electroceuticals offer scalable, non-invasive alternatives to chronic drug use

• Role of AI in driving real-time therapy optimization and patient-specific outcomes

• Top innovators including Boston Scientific, Sinaptica, and Nalu Medical

• Why multimodal systems are the next leap in non-pharmacological care

• Business and investment opportunities shaping the bioelectronic medicine frontier

This episode is essential for leaders across medtech, digital therapeutics, and chronic care innovation.

frost.com | [email protected]